Flora Corporatio

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE318U01016
  • NSEID:
  • BSEID: 540267
INR
7.50
0.05 (0.67%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 2

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2 (-99.86%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

28.13%

Why is Flora Corporation Ltd falling/rising?

20-Jun-2026

As of 19-Jun, Flora Corporation Ltd's stock price has risen slightly by 0.67%, but it remains in a longer-term downward trend with significant declines over the past week, month, and year. Despite today's increase, the stock is underperforming against its moving averages and facing reduced investor participation.

As of 19-Jun, Flora Corporation Ltd's stock price is rising slightly, with a change of 0.05, representing an increase of 0.67%. However, this upward movement occurs against a backdrop of significant declines over various time periods. Over the past week, the stock has fallen by 4.09%, and over the past month, it has decreased by 8.54%. Year-to-date, the stock is down 1.70%, and it has experienced a substantial decline of 24.92% over the past year. <BR><BR>Despite today's positive change, the stock is trading below its moving averages across all time frames, indicating a longer-term downward trend. Additionally, there has been erratic trading, with the stock not trading on 2 out of the last 20 days, and a notable decrease in investor participation, as evidenced by a 44.95% drop in delivery volume compared to the 5-day average. <BR><BR>While the stock has outperformed its sector today by 1.85%, the overall performance metrics suggest that the stock is still facing significant challenges, contributing to a generally negative outlook despite the minor rise in price today.

View full answer

What does Flora Corporatio do?

11-Jun-2026

Flora Corporation Ltd operates in the Marine & Fisheries, Scrap, and Dairy Products sectors as a Micro Cap company. As of March 2026, it reported net sales of 26 Cr and a net profit of 4 Cr.

Overview:<BR>Flora Corporation Ltd is engaged in the business of Marine & Fisheries Products, Scrap Products, and Dairy Products, operating within the Trading & Distributors industry and categorized as a Micro Cap company.<BR><BR>History:<BR>Flora Corporation Ltd was incorporated on 22 March, 1988. The company underwent a status change regarding its subsidiary, M/s. VCR8 Media Private Ltd, which was disinvested as per a Special Resolution passed on 24th April, 2018. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 26 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 4 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 7 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 24.00<BR>- Industry P/E: 22<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.45<BR>- Return on Equity: 5.65%<BR>- Price to Book: 1.33<BR><BR>Contact Details:<BR>Address: Plot No 57 Text Book Colony, Secunderabad Telangana: 500009<BR>Email: csfloracorp@gmail.com<BR>Website: http://www.floracorp.in

View full answer

How big is Flora Corporatio?

11-Jun-2026

As of 10th June, Flora Corporation Ltd has a market capitalization of 7.00 Cr, classifying it as a Micro Cap company, with recent Net Sales of 84.52 Cr and a Net Profit of 0.29 Cr. Specific values for Shareholder's Funds and Total Assets are not available.

As of 10th June, Flora Corporation Ltd has a market capitalization of 7.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, Flora Corporation reported Net Sales of 84.52 Cr and a Net Profit of 0.29 Cr.<BR><BR>The reporting period for the balance sheet data is the latest annual period. However, specific values for Shareholder's Funds and Total Assets are not available.

View full answer

Who are in the management team of Flora Corporatio?

11-Jun-2026

The management team of Flora Corporatio includes Rajesh Gandhi (Executive Director), Padamkumar Jabbarchand Gandhi (Independent Non-Executive Director), B Raja Singh (Independent Non-Executive Director), and Inturi Brahmaramba (Non-Executive Women Director).

The management team of Flora Corporatio includes the following individuals:<BR><BR>1. **Rajesh Gandhi** - Executive Director / Whole Time Director<BR>2. **Padamkumar Jabbarchand Gandhi** - Independent Non-Executive Director<BR>3. **B Raja Singh** - Independent Non-Executive Director<BR>4. **Inturi Brahmaramba** - Non-Executive Women Director<BR><BR>If you have any more questions about the company or its management, feel free to ask!

View full answer

Who are the peers of the Flora Corporatio?

11-Jun-2026

Flora Corporatio's peers include Nyssa Corp., Mystic Electron., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Hemo Organic, Aravali Sec, Triveni Enterpri, and A F Enterprises. In terms of returns, Hemo Organic leads with 102.09% over one year, while Flora Corporatio has -28.45%, better than A F Enterprises at -53.00%.

Peers: The peers of the Flora Corporatio are Nyssa Corp., Mystic Electron., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Hemo Organic, Aravali Sec, Triveni Enterpri, and A F Enterprises.<BR><BR>Quality Snapshot: Excellent management risk is observed at Flora Corporatio, while Below Average management risk is found at Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, and A F Enterprises, and Average management risk is noted at Triveni Enterpri. Mystic Electron., Hemo Organic, and Aravali Sec do not qualify for management risk assessment. In terms of Growth, Flora Corporatio and the peers Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, A F Enterprises, and Triveni Enterpri are rated Below Average, while Mystic Electron., Hemo Organic, and Aravali Sec do not qualify. For Capital Structure, Flora Corporatio, Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Triveni Enterpri, and A F Enterprises are rated Below Average, while only Flora Corporatio and Triveni Enterpri are rated Good, and Mystic Electron., Hemo Organic, and Aravali Sec do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Hemo Organic at 102.09%, while the peer with the lowest is A F Enterprises at -53.00%. Flora Corporatio's own 1-year return is -28.45%, which is better than A F Enterprises but worse than the highest return peer. Additionally, the peers Mystic Electron., Aravali Sec, and A F Enterprises have negative six-month returns.

View full answer

Are Flora Corporation Ltd latest results good or bad?

14-May-2026

Flora Corporation Ltd's latest Q4 FY26 results are poor, with a 61.70% decline in net profit and a 47.30% drop in revenue year-on-year, marking three consecutive quarters of declining revenues. Concerns about the company's viability are heightened by a decrease in promoter stake and low market capitalization.

Flora Corporation Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net profit of ₹4.20 crores, which is a significant decline of 61.70% year-on-year. Additionally, revenue fell sharply to ₹26.15 crores, down 47.30% compared to the same quarter last year. This marks the third consecutive quarter of declining revenues, raising concerns about the sustainability of the business.<BR><BR>While the operating margin improved to 16.33% from a negative margin in the previous quarter, it remains below the 22.15% achieved in Q4 FY25. The volatility in earnings and the substantial drop in both revenue and profit suggest underlying weaknesses in the company's operational performance.<BR><BR>Moreover, the decline in promoter stake from 30.20% to 28.13% over recent quarters, combined with zero institutional holdings, reflects a lack of confidence from insiders and professional investors. The company's low market capitalization of ₹7.00 crores raises further liquidity concerns.<BR><BR>Overall, the results can be characterized as poor, highlighting significant operational challenges and raising questions about the company's future viability.

View full answer

Should I buy, sell or hold Flora Corporation Ltd?

14-May-2026

When is the next results date for Flora Corporation Ltd?

10-Feb-2026

The next results date for Flora Corporation Ltd is 13 February 2026.

The next results date for Flora Corporation Ltd is scheduled for 13 February 2026.

View full answer

Is Flora Corporatio overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Flora Corporatio is considered undervalued with a PE ratio of 10.23, a PEG ratio of 0.07, and lower valuation metrics compared to peers, indicating a strong investment opportunity despite a recent stock price decline.

As of 17 November 2025, Flora Corporatio has moved from a grade of risky to very attractive, indicating a significant improvement in its valuation outlook. The company is currently undervalued, with a price-to-earnings (PE) ratio of 10.23, a price-to-book value of 1.74, and an EV to EBITDA ratio of 6.81. These ratios suggest that the stock is trading at a discount compared to its earnings and book value.<BR><BR>In comparison to its peers, Flora Corporatio's PE ratio is notably lower than that of Avanti Feeds, which stands at 16.84, and Mukka Proteins at 16.67, both of which are also rated very attractive. Additionally, Flora's PEG ratio of 0.07 highlights its growth potential relative to its valuation, further supporting the conclusion that it is undervalued. Despite a recent decline in stock price, with a one-year return of -14.36% compared to the Sensex's 9.50%, the fundamental metrics indicate that Flora Corporatio presents a compelling investment opportunity at its current valuation.

View full answer

How has been the historical performance of Flora Corporatio?

17-Nov-2025

Flora Corporatio experienced significant growth from March 2017 to March 2018, with net sales increasing from 9.18 Cr to 109.40 Cr and profit after tax rising from 0.01 Cr to 0.23 Cr, indicating a positive trend in revenue and profitability.

Answer:<BR>The historical performance of Flora Corporatio shows significant growth from the fiscal year ending March 2017 to March 2018.<BR><BR>Breakdown:<BR>In March 2018, Flora Corporatio reported net sales of 109.40 Cr, a substantial increase from 9.18 Cr in March 2017. The total operating income mirrored this growth, rising to 109.40 Cr from 9.18 Cr. The raw material cost also increased significantly to 108.10 Cr in March 2018, compared to no recorded costs in the previous year. Total expenditure, excluding depreciation, rose to 109.02 Cr from 9.06 Cr. Operating profit (PBDIT) increased to 0.39 Cr in March 2018 from 0.12 Cr in March 2017, while profit before tax surged to 0.34 Cr from 0.01 Cr. Consequently, profit after tax rose to 0.23 Cr from 0.01 Cr, leading to an earnings per share (EPS) of 0.26 in March 2018, up from 0.01 in March 2017. The operating profit margin decreased slightly to 0.34% from 1.29%, while the profit after tax margin improved to 0.21% from 0.05%. Overall, the financial performance indicates a positive trend in revenue and profitability for Flora Corporatio during this period.

View full answer

Who are the top shareholders of the Flora Corporatio?

17-Jul-2025

The top shareholders of Flora Corporatio are Muvva Sujatha with 8.2%, Tej Prakash Toshniwal at 3.61%, and individual investors collectively owning 65.04%. There are no institutional holdings from mutual funds or foreign institutional investors.

The top shareholders of Flora Corporatio include Muvva Sujatha, who holds the highest stake among promoters at 8.2%. The highest public shareholder is Tej Prakash Toshniwal, with a holding of 3.61%. Additionally, individual investors collectively own 65.04% of the company's shares. There are no institutional holdings from mutual funds or foreign institutional investors.

View full answer

What is the technical trend for Flora Corporatio?

09-Jun-2025

As of May 28, 2025, Flora Corporation's technical trend is mildly bearish, with mixed signals from indicators like the MACD, RSI, and moving averages, suggesting caution in the near term.

As of 28 May 2025, the technical trend for Flora Corporatio has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across different time frames. The weekly RSI is bearish, which adds to the cautious outlook. Moving averages on a daily basis are mildly bearish, reinforcing the overall bearish sentiment. However, both the weekly and monthly Bollinger Bands are bullish, indicating potential upward price movement. The KST shows a mildly bullish trend on the weekly but is bearish on the monthly, further complicating the picture. Dow Theory supports a mildly bullish view on both weekly and monthly charts. Overall, the current technical stance is mildly bearish with mixed indicators, suggesting caution in the near term.

View full answer

Has Flora Corporatio declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 6.50% CAGR growth in Operating Profits over the last 5 years

 
2

Negative results in Mar 26

3

Reducing Promoter Confidence

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Trading & Distributors

stock-summary
Market cap

INR 7 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

21

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

5.65%

stock-summary
Price to Book

1.27

Revenue and Profits:
Net Sales:
26 Cr
(Quarterly Results - Mar 2026)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.78%
0%
12.78%
6 Months
-8.42%
0%
-8.42%
1 Year
-24.92%
0%
-24.92%
2 Years
-40.43%
0%
-40.43%
3 Years
-51.92%
0%
-51.92%
4 Years
0%
0%
0.0%
5 Years
1.21%
0%
1.21%

Flora Corporatio for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th May 2026 Under Regulation 30 Read With 33(3)(C) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

13-May-2026 | Source : BSE

1. Audited financial results for the quarter and year ended 31.03.2026 (Attached) 2. Auditors Report for the quarter and year ended 31.03.2026 (Attached) 3. Declaration for Unmodified Opinion (Attached) 4. Appointment of Secretarial Auditor for financial year 2026-27.

Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2026

08-May-2026 | Source : BSE

Flora Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2026 2. Appointment of Secretarial Auditor for financial year 2026-27. 3. Any other business with the permission of the Chair.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

13-Apr-2026 | Source : BSE

Certificate under Reg 74(5) of SEBI (DP) regulations 2018 for the quarter ended 31.03.2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
22.52%
EBIT Growth (5y)
6.50%
EBIT to Interest (avg)
2.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
25.68
Tax Ratio
9.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-33.05%
ROE (avg)
46.74%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
21
Price to Book Value
1.28
EV to EBIT
4.25
EV to EBITDA
4.25
EV to Capital Employed
1.50
EV to Sales
0.05
PEG Ratio
0.12
Dividend Yield
NA
ROCE (Latest)
10.95%
ROE (Latest)
5.65%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Muvva Sujatha (8.2%)

Highest Public shareholder

Tej Prakash Toshniwal (4.81%)

Individual Investors Holdings

66.38%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -47.30% vs -31.32% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -61.75% vs 1,09,700.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.15",
          "val2": "49.62",
          "chgp": "-47.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.27",
          "val2": "10.99",
          "chgp": "-61.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.02",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.20",
          "val2": "10.98",
          "chgp": "-61.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.33%",
          "val2": "22.15%",
          "chgp": "-5.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -41.91% vs 30.19% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 43.62% vs -492.11% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.56",
          "val2": "50.89",
          "chgp": "-41.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.88",
          "val2": "-1.49",
          "chgp": "40.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.84",
          "val2": "-1.49",
          "chgp": "43.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.98%",
          "val2": "-2.93%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -40.61% vs 34.85% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 63.77% vs -4,261.54% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.37",
          "val2": "98.29",
          "chgp": "-40.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.96",
          "val2": "-10.82",
          "chgp": "63.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-3.92",
          "val2": "-10.82",
          "chgp": "63.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.78%",
          "val2": "-11.01%",
          "chgp": "4.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -42.86% vs 1.91% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 181.82% vs -71.05% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "84.52",
          "val2": "147.91",
          "chgp": "-42.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.32",
          "val2": "0.17",
          "chgp": "88.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.02",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.31",
          "val2": "0.11",
          "chgp": "181.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.38%",
          "val2": "0.11%",
          "chgp": "0.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
26.15
49.62
-47.30%
Operating Profit (PBDIT) excl Other Income
4.27
10.99
-61.15%
Interest
0.00
0.02
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.20
10.98
-61.75%
Operating Profit Margin (Excl OI)
16.33%
22.15%
-5.82%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -47.30% vs -31.32% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -61.75% vs 1,09,700.00% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
29.56
50.89
-41.91%
Operating Profit (PBDIT) excl Other Income
-0.88
-1.49
40.94%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.84
-1.49
43.62%
Operating Profit Margin (Excl OI)
-2.98%
-2.93%
-0.05%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -41.91% vs 30.19% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 43.62% vs -492.11% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
58.37
98.29
-40.61%
Operating Profit (PBDIT) excl Other Income
-3.96
-10.82
63.40%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-3.92
-10.82
63.77%
Operating Profit Margin (Excl OI)
-6.78%
-11.01%
4.23%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -40.61% vs 34.85% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 63.77% vs -4,261.54% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
84.52
147.91
-42.86%
Operating Profit (PBDIT) excl Other Income
0.32
0.17
88.24%
Interest
0.00
0.02
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.31
0.11
181.82%
Operating Profit Margin (Excl OI)
0.38%
0.11%
0.27%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -42.86% vs 1.91% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 181.82% vs -71.05% in Mar 2025

stock-summaryCompany CV
About Flora Corporation Ltd stock-summary
stock-summary
Flora Corporation Ltd
Micro Cap
Trading & Distributors
Flora Corporation Limited was incorporated on 22 March, 1988. The Company is engaged in the business of Marine & Fisheries Products, dealing of Scrap Products and Dairy Products. The Company had a subsidiary company M/ s. VCR8 Media Private Ltd in the beginning of the year and as on the balance sheet date. However, the Company vide Special Resolution passed on 24th April, 2018 resolved to disinvest the investment of its Wholly- Owned Subsidiary and accordingly the investments were disinvested.
Company Coordinates stock-summary
Company Details
Plot No 57 Text Book Colony , Secunderabad Telangana : 500009
stock-summary
Tel:
stock-summary
csfloracorp@gmail.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad